Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 12/2011

01.12.2011 | Editorial

An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer

verfasst von: Florian Strasser, An Van den Broek, Aminah Jatoi

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Excerpt

The European Society of Medical Oncology Symposium (ESMO) on Cancer and Nutrition convened on March 20–21, 2009, in Zurich, Switzerland. Welcoming 172 participants from 32 countries and from 4 different continents, this symposium was designed to address issues directly relevant to the interface between clinical nutrition and cancer. Was there truly a need for such a conference? The organizers of this meeting contend that the answer is “yes” and cite the following salient examples to show that nutrition really does impact cancer and cancer patients and that focusing a symposium on the interface between nutrition and cancer holds merit. …
Literatur
1.
2.
August DA, Huhmann MB (2009) A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 33(5):472–500PubMedCrossRef
3.
Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12(7):1193–1201PubMedCrossRef
4.
Blum D, Oberholzer R, Linder S, Hess J, Omlin A, Jurt G, Strasser F (2009) Secondary nutrition impact symptoms: predictors of nutritional intake response to comprehensive nutritional counseling in advanced cancer patients. ESMO Symposium Nutrition and Cancer; Abstract 10PD
5.
Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, ESPEN (2009) ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28(4):445–454PubMedCrossRef
6.
Deans DA, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC (2009) Cancer cachexia is associated with the IL10–1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 89(4):1164–1172PubMedCrossRef
7.
Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799PubMedCrossRef
8.
Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18(12):2395–2405PubMed
9.
Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manage 32(4):322–331PubMedCrossRef
10.
Huhmann MB, August DA (2008) Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutr Clin Pract 23(2):182–188PubMedCrossRef
11.
Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, Higginson I, Radbruch L, Haugen DF (2008) Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 26(23):3867–3873PubMedCrossRef
12.
Koeberle D, Saletti P, Borner M, Gerber D, Dietrich D, Caspar CB, Mingrone W, Beretta K, Strasser F, Ruhstaller T, Mora O, Herrmann R, Swiss Group for Clinical Cancer Research (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 26(22):3702–3708PubMedCrossRef
13.
Mantovani G, Madeddu C, Gramignano G, Serpe R, Massa E, Deiana L, Macciò A (2007) An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: background and design of an ongoing, phase III, randomized clinical trial. Support Cancer Ther 4(3):163–167PubMedCrossRef
14.
Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O’Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB 3rd, Fuchs CS (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22(4):648–657PubMedCrossRef
15.
Miller P, Demark-Wahnefried W, Snyder DC, Sloane R, Morey MC, Cohen H, Kranz S, Mitchell DC, Hartman TJ (2006) Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv 2(3):138–148CrossRef
16.
Ohno T, Kato S, Wakatsuki M, Noda SE, Murakami C, Nakamura M, Tsujii H (2006) Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone. Gynecol Oncol 103(1):94–99PubMedCrossRef
17.
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155PubMedCrossRef
18.
Orrevall Y, Tishelman C, Permert J, Cederholm T (2009) Nutritional support and risk status among cancer patients in palliative home care services. Support Care Cancer 17(2):153–161PubMedCrossRef
19.
Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB (2008) Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr 27(3):398–407PubMedCrossRef
20.
Ravasco P, Monteiro Grillo I, Camilo M (2007) Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr 26(1):7–15PubMedCrossRef
21.
Satia JA, Littman A, Slatore CG, Galanko JA, White E (2009) Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 169(7):815–828PubMedCrossRef
22.
Sharma R, Singh DP, Sharma OP, Sharma S (2009) Improvement of nutritional status in advanced head and neck cancer patients. ESMO Symposium Nutrition and Cancer; Abstract 17PD
23.
Tewari N, Martin-Ucar AE, Black E, Beggs L, Beggs FD, Duffy JP, Morgan WE (2007) Nutritional status affects long term survival after lobectomy for lung cancer. Lung Cancer 57(3):389–394PubMedCrossRef
24.
van den Berg MG, Rasmussen-Conrad EL, Gwasara GM, Krabbe PF, Naber AH, Merkx MA (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772PubMedCrossRef
25.
van Norren K, van Helvoort A, Argilés JM, van Tuijl S, Arts K, Gorselink M, Laviano A, Kegler D, Haagsman HP, van der Beek EM (2009) Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br J Cancer 100(2):311–314PubMedCrossRef
26.
van Norren K, Kegler D, Argilés JM, Luiking Y, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, van der Beek EM, van Helvoort A (2009) Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer 100(5):713–722PubMedCrossRef
27.
Velicer CM, Ulrich CM (2008) Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26(4):665–673PubMedCrossRef
Metadaten
Titel
An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer
verfasst von
Florian Strasser
An Van den Broek
Aminah Jatoi
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1246-1

Weitere Artikel der Ausgabe 12/2011

Supportive Care in Cancer 12/2011 Zur Ausgabe

Original Article

Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists

Original Article

Loss of lifestyle: health behaviour and weight changes after becoming a caregiver of a family member diagnosed with ovarian cancer

Original Article

Inadequate symptom control in advanced cancer patients across Europe

Review Article

Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy—clinical approach and unsolved issues

Original Article

The experience of cough in patients diagnosed with lung cancer

Short Communication

Informational and decisional empowerment in online health support communities: initial psychometric validation of the Cyber Info-Decisional Empowerment Scale (CIDES) and preliminary data from administration of the scale

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise